SynBioBeta Speaker
Kim Branson
SVP, Global Head
GlaxoSmithKline
May 2026, SynBioBeta
Speaker
Dr. Kim Branson is Senior Vice President and the Global Head of Artificial Intelligence & Machine Learning at GSK, where he leads a global team developing and applying AI methods that accelerate drug discovery and clinical development across GSKPrior to joining GSK in 2019, he served as Head of AI for Genentech and is a serial entrepreneur having previously co-founded multiple successful startups with exits including Twitter and Apple Dr. Branson earned degrees from the University of Adelaide, completed his PhD at the University of Melbourne, and undertook post-doctoral training at Stanford University establishing a deep technical foundation at the intersection of machine learning, structural biology, medicine and drug discovery.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Meals & Refreshments
Post Event Video Access
Price increases in
08:07:32:05
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
Join for the latest
SynBioBeta event updates.